Dose Optimization in Oncology: Advancing Clinical Trial Quality

The FDA’s latest guidance on dose optimization marks a pivotal shift in oncology drug development.

New FDA Guidance Reshapes Decentralized Trial Oversight

The FDA’s new guidance on marks a pivotal shift in clinical research, promoting accessibility while emphasizing the need for enhanced risk oversight.